Philippe Sauvage - 16 Jun 2025 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Role
Chief Financial Officer
Signature
/s/ Stephen Dang, Attorney-in-Fact
Issuer symbol
NUVB
Transactions as of
16 Jun 2025
Net transactions value
+$13,216
Form type
4
Filing time
18 Jun 2025, 16:05:19 UTC
Previous filing
04 Mar 2025
Next filing
03 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Sauvage Philippe Chief Financial Officer C/O NUVATION BIO INC., 1500 BROADWAY, SUITE 1401, NEW YORK /s/ Stephen Dang, Attorney-in-Fact 18 Jun 2025 0002039891

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NUVB Class A Common Stock Purchase $6,056 +3,300 +127% $1.84 5,902 16 Jun 2025 Direct F1
transaction NUVB Class A Common Stock Purchase $7,160 +4,000 +68% $1.79 9,902 17 Jun 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 2,602 shares acquired on May 19, 2025 under the Issuer's 2021 Employee Stock Purchase Plan.